The emergence of the SARS-CoV-2 Omicron variant

Hämta fulltext
Series

How is Omicron different?

Hämta fulltext
Series

SARS-CoV-2 variants implications for immunity and vaccine development /

Hämta fulltext
Series

The COVID-19 outbreak April 2021 update /

Hämta fulltext
Series

Genetic surveillance and the emergence of SARS-CoV-2 variants

Hämta fulltext
Series

The immune system response to the SARS-CoV-2 virus March 2021 update /

Hämta fulltext
Series

Impact of COVID-19 on neuropsychiatric disorder and mental health

Hämta fulltext
Series

Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state

Hämta fulltext
Series

The impact of asymptomatic infections the Italian municipality of Vo' as a case study /

Hämta fulltext
Series

SARS-CoV-2 vaccine rollout campaigns

Hämta fulltext
Series

COVID-19 epidemiology and variants new challenges and future of the pandemic /

Hämta fulltext
Series

Interspecies transmission of SARS-CoV-2

Hämta fulltext
Series

Human movement patterns and local spread of COVID-19

Hämta fulltext
Series

SARS-CoV-2 mutations phenotypes and implications for vaccine development /

Hämta fulltext
Series

The immune system response to the SARS-CoV-2 virus December 2020 update /

Hämta fulltext
Series

Triage and end of life care planning in COVID-19

Hämta fulltext
Series

Potential long-term health effects of a SARS-CoV-2 infection

Hämta fulltext
Series

The COVID-19 coronavirus outbreak October 2020 update /

Hämta fulltext
Series

Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers

Hämta fulltext
Series

Risk of re-emergence of COVID-19 after exit from lockdown

Hämta fulltext
Series